This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ensign Group (ENSG) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Ensign Group (ENSG) possesses solid growth attributes, which could help it handily outperform the market.
Why Ensign Group (ENSG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign
by Zacks Equity Research
BioMarin, Amazon.com, Leidos and The Ensign have been highlighted in this Screen of The Week article.
These 4 Stocks Boast Impressive Interest Coverage Ratio
by Sumit Singh
BMRN, AMZN, LDOS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Here's Why You Should Add Ensign Stock to Your Portfolio Now
by Zacks Equity Research
ENSG's valuation looks relatively cheap compared with the industry average.
Here's Why it is Prudent for Investors to Hold Humana Stock for Now
by Zacks Equity Research
HUM remains well-poised for growth, attributable to improved premiums, contract wins, acquisitions, collaborations and growing cash reserves.
The Zacks Analyst Blog Highlights Ensign, Cardinal Health, Atmos Energy and IDACORP
by Zacks Equity Research
Ensign, Cardinal Health, Atmos Energy and IDACORP are included in this Analyst Blog.
Consumer Sentiment Declines Amid Rate Cut Uncertainty: 4 Safe Bets
by Ritujay Ghosh
Low-beta defensive stocks like ENSG, CAH, ATO and IDA are a safe bet during times of market volatility.
Here's Why Ensign Group (ENSG) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compelling Reasons for Investors to Hold on to Centene Stock
by Zacks Equity Research
CNC remains well-poised for growth on the back of an expanding customer base, improved premiums, strategic acquisitions and commendable cash reserves.
Ensign Group Bolsters Healthcare Portfolio With Nine New Facilities
by Zacks Equity Research
ENSG acquires operations of nine skilled nursing facilities, marking its debut in Alabama and strengthening its Tennessee footprint, to enhance care and grow its Skilled Services segment.
3 Reasons Growth Investors Will Love Ensign Group (ENSG)
by Zacks Equity Research
Ensign Group (ENSG) possesses solid growth attributes, which could help it handily outperform the market.
Should You Buy, Sell or Hold Pediatrix Medical Stock at a 9.28X P/E?
by Zacks Equity Research
Stable same-facility patient volume growth, inorganic initiatives and transition to an RCM structure should aid MD's future growth.
Wall Street Top Picks: 3 Healthcare Stocks Analysts Are Bullish About
by Kaibalya Pravo Dey
The long-term outlook for the healthcare sector remains favorable, with profits expected to rise; analysts are bullish on THC, EHC and ENSG stocks.
Here's Why You Should Add Ensign Group Stock to Your Portfolio Now
by Zacks Equity Research
ENSG should benefit from expanding facilities and growing footprint, leading to higher service revenues in the future.
Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ensign Group (ENSG) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Ensign Group (ENSG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Ensign Expands Footprint With Buyout of Eight Healthcare Facilities
by Zacks Equity Research
ENSG agrees to buy eight healthcare facilities from Providence Home and Community Care, expanding its footprint.
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
by Zubia Masood
The Healthcare sector sees volume growth and improved occupancy while battling rising medical costs and regulatory uncertainty.
Ensign Group Rewards Shareholders With 4.2% Dividend Hike
by Zacks Equity Research
ENSG hikes quarterly dividend by 4.2%, maintaining its record of raising dividends for the past 22 years.
Here's Why Ensign Group (ENSG) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.